Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 7, 2005, Pages 2583-2588

  Viejo Díaz, Mónica ^a   Andrés, María T ^a   Fierro, José F ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; BREVININ 1SA; FLUCONAZOLE; KALIOCIN 1; LACTOFERRICIN H; LACTOFERRIN; PROPIDIUM IODIDE; PROTEIN LFPEP; SYNTHETIC PEPTIDE; TRANSFERRIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; DRUG PENETRATION; FROG; FUNGICIDAL ACTIVITY; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; STRAIN DIFFERENCE;

AMINO ACID SEQUENCE; AMPHIBIAN PROTEINS; ANIMALS; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CANDIDA ALBICANS; CELL MEMBRANE; HUMANS; LACTOFERRIN; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT;

EID: 21444435350     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.7.2583-2588.2005     Document Type: Article

References (36)

1. Aguilera, O., H. Ostolaza, L. M. Quirós, and J. F. Fierro. 1999. Permeabilizing action of an antimicrobial lactoferricin-derived peptide on bacterial and artificial membranes. FEBS Lett. 462:273-277.
2. Bañuelos, M. A., and A. Rodríguez-Navarro. 1998. P-type ATPases mediate sodium and potassium effluxes in Schwanniomyces occidentalis. J. Biol. Chem. 273:1640-1646.
3. Bellamy, W., M. Takase, K. Yamauchi, H. Wakabayashi, K. Kawase, and M. Tomita. 1992. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121:130-136.
4. Bellamy, W. R., H. Wakabayashi, M. Takase, K. Kawase, S. Shimamura, and M. Tomita. 1993. Role of cell binding in the antimicrobial mechanism of lactoferricin B. J. Appl. Bacteriol. 75:478-484.
5. Britigan, B. E., M. B. Hayek, B. N. Doebbeling, and R. B. Fick Jr. 1993. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61:5049-5055.
6. Cho, Y., J. S. Turner, N. N. Dinh, and R. I. Lehrer. 1988. Activity of protegrins against yeast-phase Candida albicans. Infect. Immun. 66:2486-2493.
7. Conlon, J. M., T. Halverson, J. Dulka, J. E. Platz, and F. C. Knop. 1999. Peptides with antimicrobial activity of the brevinin-1 family isolated from skin secretions of the southern leopard frog, Rana sphenocephala. J. Pept. Res. 54:522-527.
8. Conlon, J. M., Á. Sonnevend, M. Patel, C. Davidson, P. F. Nielsen, T. Pál, and L. A. Rollins-Smith. 2003. Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. J. Pept. Res. 62:207-213.
9. Devine, D. A. 2003. Antimicrobial peptides in defence of the oral and respiratory tracts. Mol. Immunol. 40:431-443.
10. Dimarcq, J. L., P. Bulet, C. Hetru, and J. Hoffmann. 1998. Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers 47:465-477.
11. Farnaud, S., and R. W. Evans. 2003. Lactoferrin - a multifunctional protein with antimicrobial properties. Mol. Immunol. 40:395-405.
12. Fehlbaum, P., P. Bulet, S. Chernysh, J. P. Briand, J. P. Roussel, L. Letellier, C. Hetru, and J. A. Hoffmann. 1996. Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc. Natl. Acad. Sci. USA 93:1221-1225.
13. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
14. Helmerhorst, E. J., P. Breeuwer, W. van't Hof, E. Walgreen-Weterings, L. C. J. M. Oomen, E. C. I. Veerman, A. V. N. Amerongen, and T. Abee. 1999. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J. Biol. Chem. 274:7286-7291.
15. Hobson, R. P. 2003. The global epidemiology of invasive Candida infections - is the tide turning? J. Hosp. Infect. 55:159-168.
16. Klepser, M. E. 2001. Antifungal resistance among Candida species. Pharmacotherapy 21:124-132.
17. Koshlukova, S. E., T. L. Lloyd, M. W. B. Araujo, and M. Edgerton. 1999. Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J. Biol. Chem. 274:18872-18879.
18. Kuipers, M. E., H. G. de Vries, M. C. Eikelboom, D. K. Meijer, and P. J. Swart. 1999. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob. Agents Chemother. 43:2635-2641.
19. Lehrer, R. I., D. Szklarek, T. Ganz, and M. E. Selsted. 1985. Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity. Infect. Immun. 49:207-211.
20. Lupetti, A., A. Paulusma-Annema, M. M. Welling, S. Senesi, J. T. van Dissel, and P. H. Nibbering. 2000. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob. Agents Chemother. 44:3257-3263.
21. Lupetti, A., R. Danesi, J. W. van't Wout, J. T. van Dissel, S. Senesi, and P. H. Nibbering. 2002. Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. Expert Opin. Investig. Drugs 11:309-318.
22. Morikawa, N., K. Hagiwara, and T. Nakajima. 1992. Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa. Biochem. Biophys. Res. Commun. 189:184-190.
23. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Nibbering, P. H., E. Ravensbergen, M. M. Welling, L. A. van Berkel, P. H. C. van Berkel, E. K. J. Pauwels, and J. H. Nuijens. 2001. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect. Immun. 69:1469-1476.
25. Odell, E. W., R. Sarra, M. Foxworthy, D. S. Chapple, and R. W. Evans. 1996. Antibacterial activity of peptides homologous to a loop region in human lactoferrin. FEBS Lett. 382:175-178.
26. Rothstein, D. M., P. Spacciapoli, L. T. Tran, T. Xu, F. D. Roberts, M. D. Serra, D. K. Buxton, F. G. Oppenheim, and P. Friden. 2001. Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob. Agents Chemother. 45:1367-1373.
27. Sajjan, U. S., L. T. Tran, N. Sole, C. Rovaldi, A. Akiyama, P. M. Friden, J. F. Forstner, and D. M. Rothstein. 2001. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Antimicrob. Agents Chemother. 45:3437-3444.
28. Situ, H., and L. A. Bobek. 2000. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC) domain 1. Antimicrob. Agents Chemother. 44:1485-1493.
29. Steinstraesser, L., B. F. Tack, A. J. Waring, T. Hong, L. M. Boo, M. H. Fan, D. I. Remick, G. L. Su, R. I. Lehrer, and S. C. Wang. 2002. Activity of novospirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob. Agents Chemother. 46:1837-1844.
30. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
31. Turchany, J. M., S. B. Aley, and F. D. Gillin. 1995. Giardicidal activity of lactoferrin and N-terminal peptides. Infect. Immun. 63:4550-4552.
32. van't Hof, W., I. M. Reijnders, E. J. Helmerhorst, E. Walgreen-Weterings, I. M. Simoons-Smit, E. C. Veerman, and A. V. Amerongen. 2000. Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity. Antonie Leeuwenhoek 78:163-169.
33. Viejo-Díaz, M., M. T. Andrés, J. Pérez-Gil, M. Sánchez, and J. F. Fierro. 2003. Potassium-efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane. Biochemistry (Moscow) 68:217-227.
34. Viejo-Díaz, M., M. T. Andrés, and J. F. Fierro. 2004. Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity. Antimicrob. Agents Chemother. 48:1242-1248.
35. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
36. Yount, N. Y., and M. R. Yeaman. 2004. Multidimensional signatures in antimicrobial peptides. Proc. Natl. Acad. Sci. USA 101:7363-7368.